Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Notable Mergers and Acquisitions 2/2: (CAMP)/(LOJN) (SYUT) (TEL) (MIK)
-
Canaccord Genuity Downgrades Alere (ALR) to Hold
-
Vanda Pharmaceuticals to Participate in the Canaccord Genuity Rare Disease, Biopharma One-on-One Day
-
Calamp Corp. (CAMP) to Acquire LoJack (LOJN) in $134M Deal
-
CalAmp to Acquire LoJack Corporation
-
CMP 2016 Resource Limited Partnership Files Final Prospectus
-
Abbott Labs to buy diagnostics company Alere for $5.8 billion
-
Notable Analyst Rating Changes 2/1: (JOY) (PFPT) (VRTX) Upgraded; (ARR) (GPC) (AIG) Downgraded
-
Canaccord Genuity Downgrades Nokia (NOK) to Hold
-
Canaccord Genuity Starts Summit Therapeutics plc (SMMT) at Buy
-
Epizyme to Present at Upcoming Investor Conferences
-
Canaccord Genuity Starts Halozyme Therapeutics (HALO) at Buy
-
Canaccord Genuity Downgrades Hersha Hospitality Trust (HT) to Hold
-
Canaccord Genuity Downgrades Ashford Hospitality Trust (AHT) to Hold
-
Canaccord Genuity Downgrades Ashford Hospitality Prime (AHP) to Hold
-
Aurinia Pharmaceuticals to Present at the Canaccord Genuity Rare Disease and Bio-Pharma One on One Day
-
NCE Diversified Flow-Through (16) Limited Partnership files final prospectus; maximum $50 million
-
Seres Therapeutics Announces Participation at Two Upcoming Investor Conferences
-
Notable Analyst Rating Changes 1/29: (POT) (BAC) (JCP) Upgraded; (DRI) (SPR) (PCP) Downgraded
-
Canaccord Genuity Starts Precision Drilling (PDS) at Hold
-
Canaccord Genuity Upgrades NetSuite (N) to Buy
-
Versartis to Host Conference Call to Review Two-Year Top-Line Data From Ongoing Extension Study of Somavaratan
-
Media Advisory: Canaccord Genuity Group Inc. - Access To Quarterly Results Information
-
Canaccord Genuity Says InvenSense (INVN) Should See Growth Over Next Several Years - Reiterates Buy
-
Canaccord Genuity Remains Sidelined as eBay's (EBAY) Transformation Gains Traction
-
Weaker Smartphone Market Drives EPS Reductions for Qualcomm (QCOM) - Canaccord Genuity
-
Horizon Pharma plc to Participate in Three Investor Conferences in February
-
Canaccord Genuity Cuts Price target on Crane Co. (CR) Following 2016 Guidance
-
UPDATE: Canaccord Genuity Downgrades Medivation (MDVN) to Hold
-
Canaccord Genuity Remains Bullish on Stryker (SYK) Following Relatively In-Line 4Q
-
UPDATE: Canaccord Genuity Downgrades Regeneron Pharma (REGN) to Hold on Slowing EYLEA Growth and Lower Praluent Revenues
-
Apple (AAPL) Results, Guidance 'Consistent' with Canaccord Genuity Estimates - Analyst
-
Dimension Therapeutics to Participate in Canaccord Genuity 2016 Rare Disease Biopharma Day and SunTrust Robinson Humphrey 2016 Orphan Drug Day
-
Atara Bio Announces Participation in Two Upcoming Investor Conferences
-
Boeing shares slide; investors brace for slow deliveries, profit hit
-
Akari Therapeutics to Participate in the 2016 Canaccord Genuity Rare Disease, BioPharma One-On-One Day
-
Marinus Pharmaceuticals to Participate in Canaccord Genuity Rare Disease Biopharma Day
-
Medgenics to Participate in the 2016 Canaccord Genuity Rare Disease, BioPharma One-On-One Day
-
Canaccord Genuity Remains Bullish on TeamHealth Holdings (TMH) Following Health Leadership Event
-
Atalaya Mining PLC: Holdings in Company
-
Orsu Metals Corporation: Update on Akdjol-Tokhtazan Project
-
Zillow (ZG) Estimates, PT Cut at Canaccord on Lower Margins
-
Canaccord Genuity Cuts Price Target on Hexcel Corp. (HXL) as 4Q Benefited From Lower Tax Rate
-
PFSweb (PFSW) Pushes to Highs on New 'Buy' Rating
-
Canaccord Genuity Remains Bullish After Meeting with IDEXX Labs (IDXX) Management
-
Canaccord Genuity Says Dick's Sporting Goods (DKS) Would Benefit From Sports Authority Store Closures - Reiterates Buy
-
Canaccord Genuity Revises Chefs' Warehouse's (CHEF) Sales Expectations to Reflect Expected Deflation - PT to $18
-
Canaccord Genuity Remains Bullish Following Proto Labs' (PRLB) Roughly 20% Sell-Off
-
UPDATE: Canaccord Genuity Starts PFSweb Inc (PFSW) at Buy
-
Veresen Announces Common Share Dividend for January 2016

